Open access
Jul 2026
Cancer treatment-related cardiovascular toxicity according to the ESC definition in patients receiving CAR T-cell therapy
Potential overclassification driven by biomarker elevations is suggested and the importance of emphasizing clinical relevance when assessing cardiotoxicity in CAR T-cell recipients is underscored.
J. Voran, C. Richard, Astrid Dempfle et al.
· Cardio-Oncology · 0 citations